CorVel Co. (NASDAQ:CRVL) Holdings Lifted by Atria Investments Inc

Atria Investments Inc increased its position in shares of CorVel Co. (NASDAQ:CRVL) by 8.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,234 shares of the business services provider’s stock after acquiring an additional 335 shares during the period. Atria Investments Inc’s holdings in CorVel were worth $1,384,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CRVL. GAMMA Investing LLC grew its holdings in shares of CorVel by 98.0% in the 2nd quarter. GAMMA Investing LLC now owns 97 shares of the business services provider’s stock worth $25,000 after acquiring an additional 48 shares during the last quarter. Blue Trust Inc. increased its stake in CorVel by 435.3% in the 3rd quarter. Blue Trust Inc. now owns 91 shares of the business services provider’s stock worth $30,000 after purchasing an additional 74 shares in the last quarter. Whittier Trust Co. of Nevada Inc. acquired a new stake in CorVel during the 3rd quarter worth about $102,000. Benjamin F. Edwards & Company Inc. lifted its stake in CorVel by 130.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 411 shares of the business services provider’s stock valued at $105,000 after buying an additional 233 shares in the last quarter. Finally, Kapitalo Investimentos Ltda acquired a new position in shares of CorVel in the third quarter worth about $208,000. 51.36% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered shares of CorVel from a “buy” rating to a “hold” rating in a report on Saturday, August 31st.

CorVel Trading Down 0.6 %

Shares of CRVL stock opened at $344.74 on Friday. The company has a market capitalization of $5.90 billion, a price-to-earnings ratio of 73.19 and a beta of 1.10. CorVel Co. has a 1-year low of $203.90 and a 1-year high of $367.84. The stock’s fifty day simple moving average is $318.73 and its 200-day simple moving average is $290.07.

Insider Buying and Selling at CorVel

In related news, Director R Judd Jessup sold 2,500 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $311.60, for a total value of $779,000.00. Following the completion of the sale, the director now owns 40,777 shares of the company’s stock, valued at approximately $12,706,113.20. The trade was a 5.78 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Brandon O’brien sold 1,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $314.98, for a total transaction of $314,980.00. Following the transaction, the chief financial officer now directly owns 6,502 shares in the company, valued at approximately $2,047,999.96. The trade was a 13.33 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 47.57% of the company’s stock.

About CorVel

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.